Titlebook: Infectious Complications in Biologic and Targeted Therapies; Carlos Cervera,Jose Maria Aguado Book 2022 The Editor(s) (if applicable) and

只看該作者 · 發(fā)表于 2025-4-1 01:54:11

CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4low-up would be needed to determine the real risk of some rare infections. This chapter evaluates the incidence, risk factors, and proposed prevention for infectious complications related to these drugs.

只看該作者 · 發(fā)表于 2025-4-1 06:42:03

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 12:15
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved